Undifferentiated connective tissue disease natural history, complications and prognosis
|
Undifferentiated connective tissue disease Microchapters |
|
Differentiating Undifferentiated connective tissue disease from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Undifferentiated connective tissue disease natural history, complications and prognosis On the Web |
|
American Roentgen Ray Society Images of Undifferentiated connective tissue disease natural history, complications and prognosis |
|
FDA on Undifferentiated connective tissue disease natural history, complications and prognosis |
|
CDC on Undifferentiated connective tissue disease natural history, complications and prognosis |
|
Undifferentiated connective tissue disease natural history, complications and prognosis in the news |
|
Blogs on Undifferentiated connective tissue disease natural history, complications and prognosis |
|
Directions to Hospitals Treating Undifferentiated connective tissue disease |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:
Overview
If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
OR
Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].
OR
Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
Natural History, Complications, and Prognosis
Natural History
- The symptoms of undifferentiated connective tissue disease(UCTD)usually are similar to connective tissue diseases but couldn't complete the criteria for their definitive diagnosis.
- If left untreated, 24.3-33% of patients with UCTD may progress to develop manifestations of well defined connective tissue disease such as systemic lupus erythematosus, rheumatoid arthritis, Sjögren's syndrome.[1][2]
Complications
- Common complications of UCTD include:[3]
- Interstitial lung disease- Non specific interstitial pneumonia
Prognosis
- Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
- Depending on the extent of the [tumor/disease progression/etc.] at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor/good/excellent.
- The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy].
- [Subtype of disease/malignancy] is associated with the most favorable prognosis.
- The prognosis varies with the [characteristic] of tumor; [subtype of disease/malignancy] have the most favorable prognosis.
References
- ↑ Danieli MG, Fraticelli P, Salvi A, Gabrielli A, Danieli G (1998). "Undifferentiated connective tissue disease: natural history and evolution into definite CTD assessed in 84 patients initially diagnosed as early UCTD". Clin. Rheumatol. 17 (3): 195–201. PMID 9694051.
- ↑ Cavazzana I, Franceschini F, Belfiore N, Quinzanini M, Caporali R, Calzavara-Pinton P, Bettoni L, Brucato A, Cattaneo R, Montecucco C (2001). "Undifferentiated connective tissue disease with antibodies to Ro/SSa: clinical features and follow-up of 148 patients". Clin. Exp. Rheumatol. 19 (4): 403–9. PMID 11491495.
- ↑ Kinder BW, Shariat C, Collard HR, Koth LL, Wolters PJ, Golden JA, Panos RJ, King TE (April 2010). "Undifferentiated connective tissue disease-associated interstitial lung disease: changes in lung function". Lung. 188 (2): 143–9. doi:10.1007/s00408-009-9226-7. PMC 2837880. PMID 20069430.